166 related articles for article (PubMed ID: 29023140)
1. Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan.
Mirzaev KB; Sychev DA; Ryzhikova KA; Konova OD; Mammaev SN; Gafurov DM; Shuev GN; Grishina EA; Sozaeva ZA
Genet Test Mol Biomarkers; 2017 Dec; 21(12):747-753. PubMed ID: 29023140
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant pharmacogenetic markers in Tatars and Balkars.
Abdullaev SP; Mirzaev KB; Burashnikova IS; Shikaleva AA; Kachanova AA; Abdullaev SP; Akmalova KA; Sozaeva ZA; Grishina EA; Sozaeva MS; Rytkin EI; Sychev DA
Mol Biol Rep; 2020 May; 47(5):3377-3387. PubMed ID: 32303955
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
4. [CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups].
Abdullaev SP; Denisenko NP; Mirzaev KB; Shuev GN; Sozaeva ZA; Kachanova AA; Mammaev SN; Kasaeva EA; Gafurov DM; Grishina EA; Sychev DA
Ter Arkh; 2021 Nov; 93(11):1334-1339. PubMed ID: 36286656
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
Sychev DA; Abdullaev SP; Mirzaev KB; Ryzhikova KA; Shuyev GN; Sozaeva ZA; Grishina EA; Mammaev SN; Gafurov DM; Kitaeva EY; Shprakh VV; Suleymanov SS; Bolieva LZ; Sozaeva MS; Zhuchkova SM; Gimaldinova NE; Sidukova EE; Asoskova AV; Mumladze RB
Mol Biol Rep; 2019 Jun; 46(3):2761-2769. PubMed ID: 30850966
[TBL] [Abstract][Full Text] [Related]
7. Major CYP450 Polymorphism among Saudi Patients.
Almeman AA
Drug Metab Lett; 2021; 14(1):17-24. PubMed ID: 32703145
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
McGrane IR; Loveland JG
J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
[TBL] [Abstract][Full Text] [Related]
9. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL
Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Sychev DA; Shuev GN; Suleymanov SS; Ryzhikova KA; Mirzaev KB; Grishina EA; Snalina NE; Sozaeva ZA; Grabuzdov AM; Matsneva IA
Pharmgenomics Pers Med; 2017; 10():93-99. PubMed ID: 28435307
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
Naujokaitis D; Asmoniene V; Kadusevicius E
Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
[TBL] [Abstract][Full Text] [Related]
13. Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers.
Chen YR; Yu X; Xu LM; Mei J; Tian ML; Xu M; Jin QY; Ye LB; Yang SX
Xenobiotica; 2024 Jan; 54(1):38-44. PubMed ID: 38085693
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A;
Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783
[TBL] [Abstract][Full Text] [Related]
15. Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
Ota T; Kamada Y; Hayashida M; Iwao-Koizumi K; Murata S; Kinoshita K
Int J Med Sci; 2015; 12(1):78-82. PubMed ID: 25552922
[TBL] [Abstract][Full Text] [Related]
16. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.
Zhou Q; Ruan ZR; Jiang B; Yuan H; Zeng S
Pharmazie; 2013 Feb; 68(2):124-8. PubMed ID: 23469684
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
